Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Asthma

Unclear guidelines mean four in five patients with severe asthma do not get proper care

Some four out of five people in England with severe asthma are not getting the care they need as a result of unclear clinical guidelines, a report by Asthma UK has said.

The report, published on 21 August 2019, used data from the Clinical Practice Research Datalink to determine that just 18% of patients with severe asthma — classified as those prescribed high-dose inhaled corticosteroids — were referred to asthma specialists in secondary care.

The remaining 82% of patients with severe asthma are losing out on “treatments that could transform their lives”, such as monoclonal antibodies that can only be prescribed by specialist clinicians and have the potential to halve the number of asthma attacks a patient has, the report said.

It concluded that patients are not being referred to secondary care because existing guidelines from the National Institute of Health and Care Excellence (NICE) fail to include criteria around when those with serve asthma should be referred.

Referral thresholds in alternative guidelines from the British Thoracic Sociality and the Scottish Intercollegiate Guidelines Network are also unclear, so clinicians have “differing perceptions” of when patients with severe asthma should be referred, leading to variation in referral rates.

Andy Whittamore, clinical lead at Asthma UK, said: “Many people with suspected severe asthma can feel frustrated and helpless because of continuous symptoms and ineffective treatments.

“If someone’s symptoms cannot be controlled, or they have more than two flare-ups requiring oral steroids, healthcare professionals should consider referring their patient to a specialist asthma clinic,” he added.

NICE has been approached for comment.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206983

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • MCQs in Clinical Pharmacy

    MCQs in Clinical Pharmacy

    Four practice tests, each with 80 practice-oriented MCQs. Assess your knowledge of clinical issues, evaluative and analytical skills.

    £25.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.